RSS

Actavis

Partner and patent attorney at intellectual property firm, Withers & Rogers, Dr Nicholas Jones, discusses why drug companies should continue to pursue new medical patents in the future, despite recent examples of legal disputes. Read more

Opinion

The UK Supreme Court (UKSC) has released its full judgment on the long running court case involving the product infringement of Eli Lilly and Company’s Alimta vitamin regimen patent — Actavis v Eli Lilly Case. Read more

News

The Competition and Markets Authority (CMA) has ruled that pharmaceutical company Actavis UK, has broken competition law by charging excessive prices to the NHS for hydrocortisone tablets. Read more

News

Aptalis Pharmaceutical Technologies has been divested from Actavis to TPG, a global private investment firm, has been completed. Read more

News

Untitled-1.jpg

Source: AstraZeneca

AstraZeneca has posted its Q4 and 2014 full year revenues. With a small increase of just 1% in full year sales, and a 15% drop in net profit, shares fell today, prompting comment from analysts. Read more

News

Pharma group Actavis has upgraded and expanded its Malta facility to accommodate almost triple growth in volume in recent years. The firm worked with Extract Technology, a supplier of containment and aseptic systems. Read more

Technology

Using a compaction simulator, Quay Pharma has helped pharmaceutical manufacturer Actavis transfer tablet production of one of its top-selling drugs to a higher throughput tabletting machine. Read more

Technology